A meta-analysis of the impact on gastrectomy versus endoscopic submucosal dissection for early stomach cancer
International Journal of Clinical Medical Research · 2023
DOI: 10.61466/ijcmr1020011 ↗Kurz gefasst
Metaanalyse in der Zeitschrift International Journal of Clinical Medical Research, 2023. Verfasst von Rajesh K. Singh. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 57 Literaturangaben.
Abstract (Originalsprache)
Background
We conducted a meta-analysis to assess the impact of gastrectomy versus endoscopic submucosal dissection for early stomach cancer.
There are-now-a-variety-of-viewpoints-on-gastrectomy-versus-endoscopic-submucosal-dissection-for-early-stomach-cancer,-and-there-are-not-many-thorough-assessments-that-are-pertinent.
Methods
A-systematic-literature-search-up-to-July-2022-was-performed-and-2456-related-studies-were-evaluated.-The-chosen-studies-comprised-15461-early-stomach-cancer-subjects-who-participated-in-the-selected-studies'-baseline-trials;-6503-of-them-used-the-endoscopic-submucosal-dissection, while 8958 used gastrectomy. Odds ratio (OR), and mean difference (MD) with 95% confidence intervals (CIs) were calculated to assess the effect of the gastrectomy versus endoscopic submucosal dissection for early stomach cancer by the dichotomous, and contentious methods with a random or fixed effect model.
Results
The use of endoscopic submucosal dissection resulted in significantly lower 5-year overall survivals (OR, 0.59; 95% CI, 0.45-0.77, p<0.001), lower the 5-year overall survival in propensity score-matched patients (OR, 0.49; 95% CI, 0.41-0.59, p<0.001), higher recurrences (OR, 6.99; 95% CI, 5,03-9.70, p<0.001), and higher synchronous lesion (OR, 7.24; 95% CI, 2.78-18.83, p<0.001), and higher metachronous lesion (OR,10.05; 95% CI, 6.44-15.67, p<0.001) compared to the gastrectomy for early stomach cancer.
However, no significant difference was found between submucosal dissection and gastrectomy for early stomach cancer in recurrence-free survival (OR, 0.74; 95% CI, 0.54-1.00, p=0.05), disease-free survival (OR, 0.43; 95% CI, 0.16-1.16, p=0.10), and disease-specific survival (OR, 1.05; 95% CI, 0.38-2.89, p=0.92).
Conclusions
The use of endoscopic submucosal dissection resulted in significantly lower 5-year overall survival, lower 5-year overall survival in propensity score-matched patients, higher recurrences, higher-synchronous lesion, and higher metachronous lesion, however, no significant difference was found in recurrence-free survival, disease-free survival, and disease-specific survival compared to the gastrectomy for early stomach cancer. The small number of studies in several comparisons calls for care when analyzing the results.
Zitieren
APA
Singh, R. K. (2023). A meta-analysis of the impact on gastrectomy versus endoscopic submucosal dissection for early stomach cancer. International Journal of Clinical Medical Research. https://doi.org/10.61466/ijcmr1020011
Vancouver
Singh RK. A meta-analysis of the impact on gastrectomy versus endoscopic submucosal dissection for early stomach cancer. International Journal of Clinical Medical Research. 2023. doi:10.61466/ijcmr1020011
BibTeX
@article{Singh2023,
author = {Singh, Rajesh K.},
title = {A meta-analysis of the impact on gastrectomy versus endoscopic submucosal dissection for early stomach cancer},
journal = {International Journal of Clinical Medical Research},
year = {2023},
doi = {10.61466/ijcmr1020011}
}
EUVIMED